IC&RC Understanding Addiction Practice Test 2026 – The All-in-One Guide to Master Your Certification!

Varenicline is primarily used as a smoking cessation aid, making it especially relevant for tobacco addiction. It acts by stimulating nicotine receptors in the brain, which helps to alleviate withdrawal symptoms and cravings associated with quitting smoking. By partially activating these receptors, it mimics the effects of nicotine while also blocking nicotine from attaching to the receptors if tobacco is consumed, thus reducing the reinforcing effects of smoking.

This mechanism of action is specifically geared towards helping individuals who are dependent on nicotine, reinforcing its classification as a treatment for tobacco addiction. In contrast, the other types of addiction mentioned do not have Varenicline as an approved treatment, as it is not effective in the management of alcohol, opioid, or stimulant addictions. Each of those substance dependencies requires different therapeutic approaches and interventions tailored to their specific physiological and psychological effects.